Health center advocates are responding to social media posts that suggest that, by freezing a Trump administration rule regarding health centers' 340B pricing on insulin, the Biden administration raised insulin's price.

Conservative News Sites Cast Shade on Biden’s Freeze on 340B Insulin Rule

Health center advocates are trying to stamp out fast-spreading claims on social media that the Biden administration, in freezing a Trump administration rule, raised the price of insulin. Facebook and Twitter have been filled with posts and counter-posts about the cost of insulin since Fox News on Jan. 23 published an article with the headline “Biden admin freezes Trump HHS rule meant to lower insulin prices.” The short article describes the new administration’s Jan. 21 decision to push back, from Jan. 22 until March 22, the effective date of the Trump administration’s rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price centers pay for those drugs under the 340B program.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »